45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,102
Insurances with rates
0
CPT / HCPCS codes
397
Source MRF
Most expensive procedures (gross)
355602
$440,405
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [186725]
Gross
$734,009
347448
$255,293
PALIVIZUMAB 50 MG/0.5 ML INTRAMUSCULAR SOLUTION [108060]
Gross
$425,489
186361
$219,119
PORACTANT ALFA 120 MG/1.5 ML INTRATRACHEAL SUSPENSION [137065]
Gross
$365,199
374926
$143,910
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [221515]
Gross
$239,850
374927
$143,910
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [221515]
Gross
$239,850
204101
$123,470
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956]
Gross
$205,784
189875
$102,740
USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE [126168]
Gross
$171,234
282910
$69,282
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [137896]
Gross
$115,470
348614
$52,574
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [184158]
Gross
$87,623
189874
$51,370
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE [126167]
Gross
$85,617
288087
$48,753
GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE [139709]
Gross
$81,255
278C172101
$47,469
HC ICD Cobalt XT DR MRI
Gross
$79,115
278C172201
$45,360
HC SUP SHELL 278 REVENUE CODE C1722 HCPCS
Gross
$75,600
4803324901
$44,435
HC EP INSJ/RPLCMT PERM DFB W/TRNSVNS LDS 1/DUAL CHMBR
Gross
$74,058
4803326401
$44,435
HC EP RMVL IMPLTBL DFB PLS GEN W/RPLCMT PLS GEN MLT LD
Gross
$74,058
324550
$42,065
LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [170336]
Gross
$70,109
212963
$41,705
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [111348]
Gross
$69,508
258274
$41,015
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [127964]
Gross
$68,358
4813336101
$40,667
HC CATH REPLACE AORTIC VALVE PERQ FEMORAL ARTRY APPROACH
Gross
$67,778
4813336201
$40,667
HC CATH REPLACE AORTIC VALVE OPENFEMORAL ARTERY APPROACH
Gross
$67,778
4813336301
$40,667
HC CATH REPLACE AORTIC VALVE OPEN AXILLRY ARTRY APPROACH
Gross
$67,778
4813336401
$40,667
HC CATH REPLACE AORTIC VALVE OPEN ILIAC ARTERY APPROACH
Gross
$67,778
4813336701
$40,667
HC CATH REPLACE AORTIC VALVE W/BYP PRQ ART/VENOUS APPRCH
Gross
$67,778
4813336801
$40,667
HC CATH REPLACE AORTIC VALVE W/BYP OPEN ART/VENOUS APRCH
Gross
$67,778
4813336901
$40,667
HC CATH REPLACE AORTA VALVE W/BYP CNTRL ART/VENOUS APRCH
Gross
$67,778
4813341801
$40,667
HC CATH TCAT MITRAL VALVE REPAIR INITIAL PROSTHESIS
Gross
$67,778
4813341901
$40,667
HC CATH TCAT MITRAL VALVE REPAIR ADDL PROSTHESIS
Gross
$67,778
3603723501
$40,051
Tibio Per Stent Ather Ea Addl
Gross
$66,752
3603723101
$39,682
Tibio Per Stent W Atherect
Gross
$66,137
3613722701
$39,682
HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/STENT/ATHERECTOMY
Gross
$66,137
271892
$38,182
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [132613]
Gross
$63,636
4803323001
$38,102
HC EP INSJ IMPLNTBL DEFIB PULSE GEN W/EXIST DUAL LEADS
Gross
$63,504
311237
$36,892
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [164576]
Gross
$61,487
4803326201
$35,939
HC EP RMVL IMPLTBL DFB PLSE GEN W/REPL PLSE GEN 1 LEAD
Gross
$59,898
4809365701
$35,496
HC EP ABLATE L/R ATRIAL FIBRIL W/ ISOLATED PULM VEIN
Gross
$59,160
3600646T01
$35,362
Transcatheter Tricuspid Valve Implantation (TTVI) replacement with prosthetic valve, percutaneous
Gross
$58,937
4810483T01
$35,362
HC CATH TMVI W/PROSTHETIC VALVE PERCUTANEOUS APPROACH
Gross
$58,937
4813334001
$35,362
HC CATH PERQ CLSR TCAT L ATR APNDGE W/ENDOCARDIAL IMPLNT
Gross
$58,937
4813347701
$35,362
HC CATH TCAT PULMONARY VALVE IMPLANTATION PRQ APPROACH
Gross
$58,937
320726
$35,284
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861]
Gross
$58,807
4800797T01
$35,088
HC Permanent Dual-Chamber Leadless Pacemaker
Gross
$58,480
262342
$34,132
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION [127653]
Gross
$56,886
329411
$33,648
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [173322]
Gross
$56,080
312856
$32,474
ALTEPLASE 100 MG INTRAVENOUS SOLUTION [9002]
Gross
$54,123
53880
$32,474
ALTEPLASE 100 MG INTRAVENOUS SOLUTION [9002]
Gross
$54,123
257172
$31,980
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [126219]
Gross
$53,300
3613722101
$31,412
HC REVASCULARIZE ILIAC ARTERY,ANGIOPLASTY/STENT, INITIAL VESSEL
Gross
$52,354
3613722501
$31,412
HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/ATHERECTOMY
Gross
$52,354
3613722601
$31,412
HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/STENT
Gross
$52,354
3613722901
$31,412
HC REVASCULARIZE TIBIAL/PERON ARTERY,ANGIOPLASTY/ATHERECTOMY INITIAL
Gross
$52,354
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 355602 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [186725] | $734,009 | $440,405 | — | — | 0 |
| 347448 | PALIVIZUMAB 50 MG/0.5 ML INTRAMUSCULAR SOLUTION [108060] | $425,489 | $255,293 | — | — | 0 |
| 186361 | PORACTANT ALFA 120 MG/1.5 ML INTRATRACHEAL SUSPENSION [137065] | $365,199 | $219,119 | — | — | 0 |
| 374926 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [221515] | $239,850 | $143,910 | — | — | 0 |
| 374927 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [221515] | $239,850 | $143,910 | — | — | 0 |
| 204101 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956] | $205,784 | $123,470 | — | — | 0 |
| 189875 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE [126168] | $171,234 | $102,740 | — | — | 0 |
| 282910 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [137896] | $115,470 | $69,282 | — | — | 0 |
| 348614 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [184158] | $87,623 | $52,574 | — | — | 0 |
| 189874 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE [126167] | $85,617 | $51,370 | — | — | 0 |
| 288087 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE [139709] | $81,255 | $48,753 | — | — | 0 |
| 278C172101 | HC ICD Cobalt XT DR MRI | $79,115 | $47,469 | — | — | 0 |
| 278C172201 | HC SUP SHELL 278 REVENUE CODE C1722 HCPCS | $75,600 | $45,360 | — | — | 0 |
| 4803324901 | HC EP INSJ/RPLCMT PERM DFB W/TRNSVNS LDS 1/DUAL CHMBR | $74,058 | $44,435 | — | — | 0 |
| 4803326401 | HC EP RMVL IMPLTBL DFB PLS GEN W/RPLCMT PLS GEN MLT LD | $74,058 | $44,435 | — | — | 0 |
| 324550 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [170336] | $70,109 | $42,065 | — | — | 0 |
| 212963 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [111348] | $69,508 | $41,705 | — | — | 0 |
| 258274 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [127964] | $68,358 | $41,015 | — | — | 0 |
| 4813336101 | HC CATH REPLACE AORTIC VALVE PERQ FEMORAL ARTRY APPROACH | $67,778 | $40,667 | — | — | 0 |
| 4813336201 | HC CATH REPLACE AORTIC VALVE OPENFEMORAL ARTERY APPROACH | $67,778 | $40,667 | — | — | 0 |
| 4813336301 | HC CATH REPLACE AORTIC VALVE OPEN AXILLRY ARTRY APPROACH | $67,778 | $40,667 | — | — | 0 |
| 4813336401 | HC CATH REPLACE AORTIC VALVE OPEN ILIAC ARTERY APPROACH | $67,778 | $40,667 | — | — | 0 |
| 4813336701 | HC CATH REPLACE AORTIC VALVE W/BYP PRQ ART/VENOUS APPRCH | $67,778 | $40,667 | — | — | 0 |
| 4813336801 | HC CATH REPLACE AORTIC VALVE W/BYP OPEN ART/VENOUS APRCH | $67,778 | $40,667 | — | — | 0 |
| 4813336901 | HC CATH REPLACE AORTA VALVE W/BYP CNTRL ART/VENOUS APRCH | $67,778 | $40,667 | — | — | 0 |
| 4813341801 | HC CATH TCAT MITRAL VALVE REPAIR INITIAL PROSTHESIS | $67,778 | $40,667 | — | — | 0 |
| 4813341901 | HC CATH TCAT MITRAL VALVE REPAIR ADDL PROSTHESIS | $67,778 | $40,667 | — | — | 0 |
| 3603723501 | Tibio Per Stent Ather Ea Addl | $66,752 | $40,051 | — | — | 0 |
| 3603723101 | Tibio Per Stent W Atherect | $66,137 | $39,682 | — | — | 0 |
| 3613722701 | HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/STENT/ATHERECTOMY | $66,137 | $39,682 | — | — | 0 |
| 271892 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [132613] | $63,636 | $38,182 | — | — | 0 |
| 4803323001 | HC EP INSJ IMPLNTBL DEFIB PULSE GEN W/EXIST DUAL LEADS | $63,504 | $38,102 | — | — | 0 |
| 311237 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [164576] | $61,487 | $36,892 | — | — | 0 |
| 4803326201 | HC EP RMVL IMPLTBL DFB PLSE GEN W/REPL PLSE GEN 1 LEAD | $59,898 | $35,939 | — | — | 0 |
| 4809365701 | HC EP ABLATE L/R ATRIAL FIBRIL W/ ISOLATED PULM VEIN | $59,160 | $35,496 | — | — | 0 |
| 3600646T01 | Transcatheter Tricuspid Valve Implantation (TTVI) replacement with prosthetic valve, percutaneous | $58,937 | $35,362 | — | — | 0 |
| 4810483T01 | HC CATH TMVI W/PROSTHETIC VALVE PERCUTANEOUS APPROACH | $58,937 | $35,362 | — | — | 0 |
| 4813334001 | HC CATH PERQ CLSR TCAT L ATR APNDGE W/ENDOCARDIAL IMPLNT | $58,937 | $35,362 | — | — | 0 |
| 4813347701 | HC CATH TCAT PULMONARY VALVE IMPLANTATION PRQ APPROACH | $58,937 | $35,362 | — | — | 0 |
| 320726 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861] | $58,807 | $35,284 | — | — | 0 |
| 4800797T01 | HC Permanent Dual-Chamber Leadless Pacemaker | $58,480 | $35,088 | — | — | 0 |
| 262342 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION [127653] | $56,886 | $34,132 | — | — | 0 |
| 329411 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [173322] | $56,080 | $33,648 | — | — | 0 |
| 312856 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION [9002] | $54,123 | $32,474 | — | — | 0 |
| 53880 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION [9002] | $54,123 | $32,474 | — | — | 0 |
| 257172 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [126219] | $53,300 | $31,980 | — | — | 0 |
| 3613722101 | HC REVASCULARIZE ILIAC ARTERY,ANGIOPLASTY/STENT, INITIAL VESSEL | $52,354 | $31,412 | — | — | 0 |
| 3613722501 | HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/ATHERECTOMY | $52,354 | $31,412 | — | — | 0 |
| 3613722601 | HC REVASCULARIZE FEM/POP ARTERY,ANGIOPLASTY/STENT | $52,354 | $31,412 | — | — | 0 |
| 3613722901 | HC REVASCULARIZE TIBIAL/PERON ARTERY,ANGIOPLASTY/ATHERECTOMY INITIAL | $52,354 | $31,412 | — | — | 0 |
Showing top 50 of 6,102 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.